PhaseV, which has a presence in both the US and Israel, is developing a unique set of advanced technologies and innovative statistical methods to revolutionize trial design, execution, and analysis.
The company was present at Bio-Europe in Munich late last year, where Deeptech Digest caught up with the CEO and co-founder, Raviv Pryluk.
Jim Cornall is editor of Deeptech Digest and publisher at Ayr Coastal Media. He is an award-winning writer, editor, photographer, broadcaster, designer and author. Contact Jim here.
